COVID-19 Update

COVID-19 has imposed an unsettling situation upon our community and our business, but at Cleveland Diabetes Care and our affiliates, KRS Global Biotechnology and Complete Pharmacy Medical Solutions, we are committed to fighting back the best way we know how. By providing better medicine for better lives we will continue operations that include creation and distribution of life saving medications and testing kits to all reaches of our great nation.

KRS Global Blog

14

August
2013

category:

503b Compounding

Rumor Mill: FDA issuing 483 Letters in Effort to Support S.959

The rumor mill is a buzz with claims from sterile compounders across the country that the FDA is making sweeping inspections to build a case to support their power grab for control of the compounding space through Senate Bill 959. The FDA is claiming that pharmacies that engage in large-scale drug compounding, produce drugs in anticipation of individual […]

read more

14

August
2013

category:

503b Compounding

Today’s Shortages

ASHP/FDA Acetazolamide Injection Amiodarone Hydrochloride Injection Ampicillin Sulbactam Atorvastatin Tablets Azithromycin Injection Bupivacaine with epinephrine Injection Calcium Gluconate Injection Cefazolin Injection Epinephrine Injection Fosphenytoin Injection Lidocaine with Epinephrine Injection Oxytocin Injection Rivastigmine Transdermal Patch Sufentanil Injection http://www.ashp.org/Drugshortages/Current/?sort=2

read more

14

August
2013

category:

503b Compounding

GAO Recommends Congress Clarify FDA’s Authority To Oversee Drug Compounding

The Government Accountability Office (GAO) released a report updating its 2003 testimony regarding drug compounding. The report was commissioned by the House Committee on Oversight and Government Reform last October and addressed: (i) the status of FDA’s authority to oversee drug compounding and the gaps between federal and state authority; (ii) how FDA has used […]

read more